Christian Hampp, PhD (he/him/his)

Sr. Director, Pharmacoepidemiology
Regeneron Pharmaceuticals

Poster(s):

• (063) Identifying the Period of Heightened Risk for Adrenal Insufficiency in Patients with Advanced Non-Small Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (065) Incidence of any Infections and SARS-COV-2 infections in Patients Receiving Treatment for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Real-World Evidence from a Large US National Claims Database
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (066) Incidence of Infections in Clinical Trials of Treatments for Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-Analysis
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST